Navigation Links
Harnessing microbes, one by one, to build a better nanoworld

Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the introduction of the Applied Biosystems Advanced Gene Expression Service Provider Program, a new program for service providers who are interested in accessing Applied Biosystems comprehensive solution for gene expression analysis, including the highly sensitive Expression Array System for whole genome analysis and gold-standard TaqMan® Gene Expression Assays for target validation. The program includes a bundled product option for the entire gene expression workflow application and technical and promotional support that is expected to enhance service providers?business offerings.

The program, intended to assist service providers in genetic analysis using interpretation tools and content to advance scientific research while helping them achieve necessary return on investment, was announced today in advance of this weekend’s annual World Microarray Congress in Vancouver, Canada.

The Applied Biosystems Expression Array System forms the technical platform for the program and can be optionally bundled with companion products that comprise Applied Biosystems?whole solution for gene expression analysis, including microarrays for human, mouse, and rat, TaqMan® Gene Expression Assays, and Real-Time PCR Systems.

Additional data analysis and promotional support is included with the Applied Biosystems Advanced Gene Expression Service Provider Program. Participants will have access to the Celera Discovery System?Online Platform and Panther?Protein Classification System, a Service Provider web link on the Applied Biosystems Web site, and on-site seminars to educate customers to help provide increased business opportunities.

“Under the program, organizations offering gene expression analysis services can now offer their clients a complete gene expression analysis system backed with technical and promotional support package from the leader in gene expression technologies ,?said Catherine M. Burzik, President of Applied Biosystems.

The Applied Biosystems Expression Array System is a highly sensitive gene expression detection system. The system detects more genes and achieves more than a 10-fold increase in sensitivity while using less sample for the detection of genes expressed at very low levels compared with conventional fluorescent microarrays. The system uses a chemiluminescence-detection instrument, software, and chemistries to deliver unambiguous gene results that are highly sensitive and reproducible.

The PCR process and the 5' nuclease detection process are covered by patents owned by Roche Molecular System, Inc. and F. Hoffmann-La Roche Ltd ("Roche"). Performing services using these patented processes may require additional licenses from Applied Biosystems or Roche.

For more information, visit http://docs.appliedbiosystems.com/pebiodocs/00114098.pdf


'"/>

Source:


Related biology news :

1. Harnessing genomic research
2. Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
3. Timing is everything: First step in protein building revealed
4. Signaling protein builds bigger, better bones in mice
5. Structure-building cell signals also may influence learning and memory
6. Carnegie Mellon scientists create PNA molecule with potential to build nanodevices
7. Scientist uses form to explain function of key building blocks of life
8. Mouse study: New muscle-building agent beats all previous ones
9. University of Utah to help build bionic arm
10. UC San Diego partners with Venter Institute to build marine microbial genomics cyberinfrastructure
11. Intensive statin therapy may partially reverse plaque build-up in arteries
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2017)... , Feb. 9, 2017 The biomass ... analysis of the biomass boiler market globally in terms ... of biomass boilers. The market for biomass boilers has ... type, end-user, application, and country/region. The market based on ... & forest residues, biogas & energy crops, urban residues, ...
(Date:2/8/2017)... 7, 2017 Report Highlights ... The global synthetic-biology market reached ... by 2021, growing at a compound annual growth rate (CAGR) ... of the global markets for synthetic biology. - Analyses of ... and projections of compound annual growth rates (CAGRs) through 2021. ...
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
Breaking Biology News(10 mins):
(Date:2/21/2017)... and VANCOUVER, British Columbia , Feb. 21, ... today announced that apatorsen results from two randomized Phase 2 ... Oncology (ASCO) 2017 Genitourinary Cancers Symposium, held February 16 th ... Clinical data from trials in bladder and prostate cancers demonstrated ... combination with standard-of-care treatments. ...
(Date:2/21/2017)... 21, 2017 Scientists From Two ... by Plastic Industry  ... STEER, creator of advanced materials ... the fields of plastics, pharmaceuticals, food and nutraceuticals, biomaterials and ... leading science & technology company, on creating co-rotating twin ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... announce that it has been approved for full, active membership in the Canadian ... Texas, was founded by Chief Executive Officer Jeff Olson in 2011. ...
(Date:2/20/2017)... -- This report analyzes the worldwide markets for Biofuel Enzymes ... Cellulase, and Others. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Read the full report: ... for the period 2015 through 2022. Also, a six-year historic ...
Breaking Biology Technology: